Elixir Pharmaceuticals Inc Cambridge, MA - 02139

Elixir Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Cambridge, MA .

Elixir Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.

If you are seeking more information, feel free to contact Paul Martha, Chief Executive Officer at the company’s single location by writing to 320 Putnam Avenue, Cambridge, Massachusetts MA 02139 or by phoning (617) 995-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Elixir Pharmaceuticals Inc
Contact Person: Paul Martha, Chief Executive Officer
Address: 320 Putnam Avenue, Cambridge, Massachusetts 02139
Phone Number: (617) 995-7000
Annual Revenue (USD): $50.000.000 to $99.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 4242101
Share This Business:

Elixir Pharmaceuticals Inc was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.

Feel free to contact Paul Martha, Chief Executive Officer for inquiries that concern Elixir Pharmaceuticals Inc by calling the company number (617) 995-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of Elixir Pharmaceuticals Inc can be found at the coordinates 42.36156,-71.11335 as well as the street address 320 Putnam Avenue in Cambridge, Massachusetts 02139.

For its online presence, you may visit Elixir Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.